Theragenics to Distribute the AccuBoost(R) Technology for Treatment of Early Stage Breast Cancer
Non-Invasive Brachytherapy Treatment Supplements Breast Conservation Therapy
BUFORD, Ga.--(Healthcare Sales & Marketing Network)--Theragenics Corporation®, a medical device company serving the cancer treatment and surgical product markets, has reach... Devices, Oncology, DistributionTheragenics, Advanced Radiation Therapy, AccuBoost, brachytherapy, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 30, 2015 Category: Pharmaceuticals Source Type: news
Additional radiation reduces breast-cancer recurrence for some patients: Hamilton study
(McMaster University) A study has found no increase in overall survival but a reduction in breast cancer recurrence when additional radiation is given to the lymph nodes as well as the standard treatment of whole-breast irradiation after breast-conserving surgery. The research, which examined the addition of regional nodal irradiation to whole-breast irradiation compared with whole-breast irradiation alone, was published July 22 in the prestigious New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2015 Category: Cancer & Oncology Source Type: news
GE Capital backs Cianna Medical in $8m round
Cianna Medical said today that it raised $8 million for its Savi Scout breast cancer device, including a $4 million debt round from GE Capital and another $4 million equity round from existing backers.
Aliso Viejo, Calif.-based Cianna’s Savi Scout is designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures.
The surgeon uses a hand piece that emits infrared light and electromagnetic waves to locate a reflector placed in target tissue as long as a week before surgery. After reaching the surgical bulls-eye, the surgeon takes out the target tissu...
Source: Mass Device - July 16, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Surgical Women's Health Breast Cancer Cianna Medical Source Type: news
Excellent Outcomes With Partial-Breast IrradiationExcellent Outcomes With Partial-Breast Irradiation
An accelerated 1-week regimen of partial-breast irradiation after breast-conserving surgery looks to be as effective as whole-breast irradiation. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 2, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Breast cancer treatment with fewer potential side effects has equally good patient outcomes, UCLA study shows
A new study by UCLA scientists has found that women diagnosed with breast cancer and treated with a one-week regimen of partial breast radiation after the surgical removal of the tumor, or lumpectomy, saw no increase in cancer recurrence or difference in cosmetic outcomes compared to women who received radiation of the entire breast for a period of up to six weeks after surgery. The study is one of the largest ever done on partial breast irradiation.
The study lasted two decades and was led by Dr. Mitchell Kamrava, an assistant professor of radiation oncology at UCLA and member of the Jonsson Comprehensive Cancer Center. ...
Source: UCLA Newsroom: Health Sciences - June 26, 2015 Category: Universities & Medical Training Source Type: news
Persistent Barriers Exist to Breast-Conserving TherapyPersistent Barriers Exist to Breast-Conserving Therapy
More women with early-stage breast cancer are receiving breast-conserving therapy, but demographic and socioeconomic disparities persist. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 23, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Breast-Conserving Tx Keeps Growing, but Disparities Persist (CME/CE)
(MedPage Today) -- Use of BCT for early breast cancer often hinges on socioeconomic factors (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - June 21, 2015 Category: Surgery Source Type: news
More women with breast cancer choose lumpectomy
Breast-conserving surgery is becoming more common for early cancers (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 19, 2015 Category: Consumer Health News Source Type: news
More Breast Cancer Patients Opting for Lumpectomy: Study
Experts often recommend this breast-conserving surgery, but many with early disease still choose mastectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 17, 2015 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Surgery, News, Source Type: news
More Breast Cancer Patients Opting for Lumpectomy
Experts often recommend this breast-conserving surgery, but many with early disease still choose mastectomy
Source: HealthDay
Related MedlinePlus Pages: Breast Cancer, Mastectomy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 17, 2015 Category: Consumer Health News Source Type: news
Breast-Conserving Therapy for Early-stage Cancers has Increased Substantially, Though Access Remains an Issue
The first comprehensive national review of breast-conserving therapy
(BCT) shows that over the last 13 years rates of this treatment modality
for early-stage breast cancer have increased at a steady pace. However,
the review also highlights important demographic factors that impact
which patients have access to BCT. Researchers at The University of Texas MD Anderson Cancer Center
found declines in disparities related to age, treatment facility type
and geographic region, but also identified several socioeconomic factors
- insurance, income and travel distance to treatment centers - as key
barriers to BCT. (Source: ...
Source: M. D. Anderson Cancer Center - News Releases - June 17, 2015 Category: Cancer & Oncology Source Type: news
Food dye, near infrared light can aid in breast resection
Roughly 1 in 4 women having breast conserving surgery (BCS) return to the surgical suite for further resection because of cancerous tissue left behind due to unclear margins. A research team focuses on coming up with a practical solution that both preserves the surgical practice of inking the margins of breast cancer tumors, and allows quality imaging post-inking. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 12, 2015 Category: Science Source Type: news
Eligible for breast conserving therapy, many still choose mastectomy
(Brigham and Women's Hospital) New research led by Brigham and Women's Hospital finds that breast conserving therapy -- or the removal of less breast tissue via a lumpectomy -- was successful in more than 90 percent of patients with triple-negative breast cancer who became eligible for this procedure after treatment with chemotherapy. Despite these findings, 31 percent who were eligible for breast conserving therapy chose to have the entire breast removed via mastectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2015 Category: Cancer & Oncology Source Type: news
East African Environmental Activist Wins Major Prize
By Lisa VivesNEW YORK, Apr 22 2015 (IPS)On Earth Day, Apr. 22, Kenyan activist Phyllis Omido takes the stage in Washington DC to receive the Goldman Environmental Prize for her efforts to defend her community from lead poisoning and force the closure of a lead smelting plant that was emitting fumes and spewing untreated acid wastewater into streams, poisoning the neighbourhood – including her own baby.Courtesy of the Goldman Prize.“At first we thought he had malaria or typhoid, but doctors found he was suffering from lead poisoning,” Omido recalled. The lead was traced to a smelter where Phyllis had recently started ...
Source: IPS Inter Press Service - Health - April 22, 2015 Category: Global & Universal Authors: Lisa Vives Tags: Active Citizens Africa Civil Society Environment Headlines Health Newsbrief TerraViva United Nations Goldman Environmental Prize Phyllis Omido Source Type: news
Too Many DCIS Patients Undergo Axillary Evaluation (CME/CE)
(MedPage Today) -- Oncology experts recommend against axillary lymph node evaluation in breast conserving surgery. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 10, 2015 Category: Hematology Source Type: news
